Under the deal, Tilray and Sandoz will supply nonsmokable and noncombustible medical cannabis products where they are legal. In addition, the two companies may co-brand certain products and develop new ones.
“This agreement represents a major milestone in the movement to provide access to safe, GMP-certified medical cannabis to patients in need across the world,” said Tilray CEO Brendan Kennedy.
The agreement marks the first of its kind for medical marijuana and a major milestone for the pharma industry, STAT reports.
More articles on pharmacy:
Pharmaceutical company files for bankruptcy, receives $200M takeover bid
Merck’s global human health president to step down, advise CEO
Kroger launches discount program for out-of-pocket prescription drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.